AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Lilly buoyed by findings on Evista.
Byline: Jeff Swiatek
Apr. 18--An osteoporosis drug made by Eli Lilly and Co. also prevents breast cancer in older, high-risk women just as well as today's standby tamoxifen -- but with fewer side effects, the National Cancer Institute announced Monday.
The five-year government study showed that Evista reduced by 50 percent the risk of developing invasive breast cancer among women who were at risk of getting the disease. That was comparable to the other drug studied in the trial, Nolvadex, which is a currently approved treatment for breast cancer.
The finding, coming out of one of the largest breast cancer prevention clinical trials ever conducted, …
-
- Eli Lilly Osteoporosis Drug May Aid Older Women's Memory, Study Suggests.
-
News wire article from: The Indianapolis Star (Indianapolis, IN)
April 19, 2001
700+ words
-
- IU Cancer Center to get $6.8M more.
-
News wire article from: The Indianapolis Star (Indianapolis, IN)
June 6, 2006
700+ words
-
- Lifes sciences are king for IU incubator chief.
-
News wire article from: The Indianapolis Star (Indianapolis, IN)
December 5, 2006
700+ words
-
- Q&A with BioCrossroads CEO: Help life sciences grow.
-
News wire article from: The Indianapolis Star (Indianapolis, IN)
January 2, 2007
700+ words
-
- Study Shows Eli Lilly Drug May Cut Patients' Cholesterol.
-
News wire article from: The Indianapolis Star (Indianapolis, IN)
March 22, 2001
700+ words
